Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Announcements
Vishal Patel

As the role of immunotherapies extends to earlier treatment lines in the nonmelanoma skin cancer treatment armamentarium, increased attention to patient characteristics and disease factors is crucial to ensure all patients receive tolerable therapies at the optimal time during the course of their disease, according to Vishal Patel, MD, FAAD, FACMS.

Read the OncLive® article.

Latest News

Micael Lopez-Acevedo, MD
Micael Lopez-Acevedo, MD, Returns to GW Cancer Center to Lead Gynecologic Oncology
When Micael Lopez-Acevedo, MD, stepped back onto the George Washington University (GW) campus, it felt like a return to familiar ground. Years earlier, he had been part of the GW Cancer Center community, working closely with faculty, trainees, and researchers. Now, as the new Division Director of…
Nagla Abdel-Karim
From Personal Loss to Purpose: Nagla Abdel Karim, MD, Joins the GW Cancer Center
From her father’s illness to groundbreaking clinical trials, Dr. Nagla Karim joins GW with a mission to advance lung cancer treatment and compassionate, whole-person care.
Grey's Anatomy actor, James Pickens, Jr.
When the Doctor Becomes the Patient
When actor and long-time television doctor James Pickens Jr. stepped into his own physician’s shoes, he faced a reality familiar to many men: a prostate cancer diagnosis. After decades playing Dr. Richard Webber on Grey’s Anatomy, he learned that his personal risk, shaped by family history and race…